Cd39 and P2rx7-Wnt signaling enhance blast pathogenicity in an experimental model of acute myeloid leukemia
Open Access
- 15 August 2024
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 110 (1) , 212-217
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Therapeutic Targeting of the Leukaemia MicroenvironmentInternational Journal of Molecular Sciences, 2021
- The Role of Trogocytosis in the Modulation of Immune Cell FunctionsCells, 2021
- Targeting ectonucleotidases to treat inflammation and halt cancer development in the gutBiochemical Pharmacology, 2021
- P2X receptors in cancer growth and progressionBiochemical Pharmacology, 2021
- Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid LeukemiaCancer Discovery, 2020
- The yin and yang functions of extracellular ATP and adenosine in tumor immunityCancer Cell International, 2020
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targetsImmunological Reviews, 2017
- Waif1/5T4 Inhibits Wnt/β-Catenin Signaling and Activates Noncanonical Wnt Pathways by Modifying LRP6 Subcellular LocalizationDevelopmental Cell, 2011
- Vascular CD39/ENTPD1 Directly Promotes Tumor Cell Growth by Scavenging Extracellular Adenosine TriphosphateNeoplasia, 2011
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in MiceGastroenterology, 2010